Ketevan Barbakadze

Statistics

Publications

Citations

243

H-Index

Active since

2009

Affiliations

National Center for Tuberculosis and Lung Disease(Current)

Emory University

University of Florida

King Khalid University

Translational Therapeutics (United States)

Ketevan Barbakadze is an author at National Center for Tuberculosis and Lung Disease specializing in pharmacy, clinical pharmacology, and multidrug-resistant tuberculosis treatment.

Publications per year

2009–2022

Publications

Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens

R. R. Kempker, Lali Mikiashvili, Ying Zhao et al. · Clinical Infectious Diseases · 2019 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia.

Lamara Vashakidze, Archil Salakaia, Natalia Shubladze et al. · PubMed · 2009 · 48 citations · Full text

Public Health, Preventive Medicine, Clinical Pharmacology +16

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis

Wael A. Alghamdi, Mohammad H. Al‐Shaer, Guohua An et al. · Antimicrobial Agents and Chemotherapy · 2020 · 44 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis

Wael A. Alghamdi, Abdullah Alsultan, Mohammad H. Al‐Shaer et al. · Antimicrobial Agents and Chemotherapy · 2019 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection

Mohammad H. Al‐Shaer, Wael A. Alghamdi, Abdullah Alsultan et al. · Antimicrobial Agents and Chemotherapy · 2019 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 7